Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy
暂无分享,去创建一个
[1] K. Belosludtsev,et al. BKCa Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy , 2022, Pharmaceutics.
[2] A. Tinker,et al. The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction , 2022, Communications Biology.
[3] D. Kass,et al. Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy , 2022, JCI insight.
[4] J. C. Calderón,et al. Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research , 2022, Frontiers in Physiology.
[5] K. Belosludtsev,et al. The Effect of Uridine on the State of Skeletal Muscles and the Functioning of Mitochondria in Duchenne Dystrophy , 2022, International journal of molecular sciences.
[6] E. Gottlieb,et al. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients , 2022, International journal of molecular sciences.
[7] A. Michelucci,et al. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy , 2022, The Journal of general physiology.
[8] Jessica L. Braun,et al. Sarco(endo)plasmic reticulum Ca2+-ATPase function is impaired in skeletal and cardiac muscles from young DBA/2J mdx mice , 2022, iScience.
[9] C. G. Perry,et al. Mitochondrial Stress Responses in Duchenne muscular dystrophy: Metabolic Dysfunction or Adaptive Reprogramming? , 2022, American journal of physiology. Cell physiology.
[10] K. Belosludtsev,et al. Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice , 2022, Bulletin of Experimental Biology and Medicine.
[11] E. Pierantozzi,et al. The Sarcoplasmic Reticulum of Skeletal Muscle Cells: A Labyrinth of Membrane Contact Sites , 2022, Biomolecules.
[12] F. Salloum,et al. Cardiovascular Disease in Duchenne Muscular Dystrophy , 2022, JACC. Basic to translational science.
[13] G. Tremblay,et al. CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy , 2022, Neurotherapeutics.
[14] G. Babu,et al. Reducing sarcolipin expression improves muscle metabolism in mdx mice. , 2022, American journal of physiology. Cell physiology.
[15] P. Pinton,et al. Molecular mechanisms and consequences of mitochondrial permeability transition , 2021, Nature Reviews Molecular Cell Biology.
[16] T. Larcher,et al. TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD , 2021, Journal of translational medicine.
[17] G. Messina,et al. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. , 2021, Experimental cell research.
[18] F. Rivier,et al. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients , 2021, International journal of molecular sciences.
[19] H. Sakurai,et al. Orai1–STIM1 Regulates Increased Ca2+ Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells , 2021, Biomedicines.
[20] K. Belosludtsev,et al. Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis , 2021, International journal of molecular sciences.
[21] K. Belosludtsev,et al. Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient mdx Mice , 2021, Biomedicines.
[22] E. Ignatieva,et al. Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype , 2021, International journal of molecular sciences.
[23] E. Clementi,et al. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy. , 2021, Pharmacological research.
[24] B. Attali,et al. Targeting of Potassium Channels in Cardiac Arrhythmias. , 2021, Trends in pharmacological sciences.
[25] D. Duan,et al. Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies , 2021, Frontiers in Physiology.
[26] A. Zimna,et al. The role of mitochondria in Duchenne muscular dystrophy. , 2021, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[27] Zachary J. Crowley-McHattan,et al. A Review of the Role of Endo/Sarcoplasmic Reticulum-Mitochondria Ca2+ Transport in Diseases and Skeletal Muscle Function , 2021, International journal of environmental research and public health.
[28] V. Mouly,et al. Treatment with a triazole inhibitor of the mitochondrial permeability transition pore fully corrects the pathology of sapje zebrafish lacking dystrophin. , 2021, Pharmacological research.
[29] J. Rieusset,et al. Metformin Reverses the Enhanced Myocardial SR/ER–Mitochondria Interaction and Impaired Complex I-Driven Respiration in Dystrophin-Deficient Mice , 2021, Frontiers in Cell and Developmental Biology.
[30] Lai-Hua Xie,et al. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice. , 2020, American journal of physiology. Heart and circulatory physiology.
[31] K. Belosludtsev,et al. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy , 2020, International journal of molecular sciences.
[32] C. G. Perry,et al. Mitochondrial bioenergetic dysfunction in the D2.mdx model of Duchenne muscular dystrophy is associated with microtubule disorganization in skeletal muscle , 2020, PloS one.
[33] E. Olson,et al. Gene Therapy with the DWORF Micropeptide Attenuates Cardiomyopathy in Mice. , 2020, Circulation research.
[34] K. Belosludtsev,et al. Transport of Ca2+ and Ca2+-dependent permeability transition in heart mitochondria in the early stages of Duchenne muscular dystrophy. , 2020, Biochimica et biophysica acta. Bioenergetics.
[35] J. Mendell,et al. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy , 2020, JAMA neurology.
[36] G. Aguiari,et al. The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective. , 2020, Biochimica et biophysica acta. Molecular basis of disease.
[37] C. Xie,et al. Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis , 2020, BioMed research international.
[38] J. Wojcik,et al. Protective effects of rimeporide on left ventricular function in golden retriever muscular dystrophy dogs. , 2020, International journal of cardiology.
[39] J. Kira,et al. iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin , 2020, BMC Musculoskeletal Disorders.
[40] Jose A. Adams,et al. Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice , 2020, Frontiers in Physiology.
[41] R. Hajjar,et al. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] K. Belosludtsev,et al. Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition. , 2020, Biochimica et biophysica acta. Molecular basis of disease.
[43] S. Robson,et al. Total absence of dystrophin expression exacerbates ectopic myofiber calcification, fibrosis, and alters macrophage infiltration patterns. , 2019, The American journal of pathology.
[44] Lai-Hua Xie,et al. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy. , 2019, American journal of physiology. Cell physiology.
[45] S. Nelson,et al. Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models , 2019, Molecular therapy. Nucleic acids.
[46] K. Belosludtsev,et al. Mitochondrial Ca2+ Transport: Mechanisms, Molecular Structures, and Role in Cells , 2019, Biochemistry (Moscow).
[47] M. Puurand,et al. On the role of tubulin, plectin, desmin, and vimentin in the regulation of mitochondrial energy fluxes in muscle cells. , 2019, American journal of physiology. Cell physiology.
[48] U. Schlattner,et al. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylation , 2019, Journal of cachexia, sarcopenia and muscle.
[49] J. Metzger,et al. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo. , 2018, American journal of physiology. Heart and circulatory physiology.
[50] P. Pinton,et al. IP3 receptor blockade restores autophagy and mitochondrial function in skeletal muscle fibers of dystrophic mice. , 2018, Biochimica et biophysica acta. Molecular basis of disease.
[51] K. Hilber,et al. Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart , 2018, International journal of molecular sciences.
[52] A. Nakamura,et al. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition. , 2018, Biochemical and biophysical research communications.
[53] J. Quadrilatero,et al. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology , 2018, Human molecular genetics.
[54] Z. Bhat,et al. ABC of multifaceted dystrophin glycoprotein complex (DGC) , 2018, Journal of cellular physiology.
[55] R. González-Ramírez,et al. Biochemical and Functional Interplay Between Ion Channels and the Components of the Dystrophin-Associated Glycoprotein Complex , 2018, The Journal of Membrane Biology.
[56] E. Conte,et al. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] M. Antal,et al. SOCE Is Important for Maintaining Sarcoplasmic Calcium Content and Release in Skeletal Muscle Fibers. , 2017, Biophysical journal.
[58] P. Bernardi,et al. Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy , 2017, Pharmacological research.
[59] J. McArdle,et al. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice , 2017, Nature Communications.
[60] S. Matecki,et al. ER stress disturbs SR/ER-mitochondria Ca2+ transfer: Implications in Duchenne muscular dystrophy. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[61] Andrew W. Trafford,et al. Calcium and Excitation-Contraction Coupling in the Heart , 2017, Circulation research.
[62] A. M. Leone,et al. A current approach to heart failure in Duchenne muscular dystrophy , 2017, Heart.
[63] N. Hempel,et al. Mitochondria control store‐operated Ca2+ entry through Na+ and redox signals , 2017, The EMBO journal.
[64] K. Hilber,et al. Decreased inward rectifier potassium current IK1 in dystrophin-deficient ventricular cardiomyocytes , 2016, Channels.
[65] M. Periasamy,et al. Sarcolipin: A Key Thermogenic and Metabolic Regulator in Skeletal Muscle , 2016, Trends in Endocrinology & Metabolism.
[66] Reija Autio,et al. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress. , 2016, Free radical biology & medicine.
[67] David W. Hammers,et al. Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts , 2016, Journal of the American Heart Association.
[68] D. Garry,et al. Dystrophin-Deficient Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[69] A. Manzur,et al. Corticosteroids for the treatment of Duchenne muscular dystrophy. , 2016, The Cochrane database of systematic reviews.
[70] R. Hajjar,et al. Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels. , 2016, Cell calcium.
[71] U. Giovanella,et al. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle , 2016, Development.
[72] M. Periasamy,et al. Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase? , 2016, Journal of molecular and cellular cardiology.
[73] H. Cai,et al. Adenosine triphosphate-sensitive potassium channels and cardiomyopathies (Review). , 2016, Molecular medicine reports.
[74] Stephen C. Cannon,et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle , 2016, Science.
[75] D. Allen,et al. Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. , 2016, Physiological reviews.
[76] C. Bruno,et al. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis. , 2015, The American journal of pathology.
[77] S. Cooper,et al. Membrane Injury and Repair in the Muscular Dystrophies , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[78] R. Perlingeiro,et al. Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo , 2015, Molecular therapy. Methods & clinical development.
[79] A. Teti,et al. P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy , 2015, PLoS medicine.
[80] J. Wilkinson,et al. Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice , 2015, PloS one.
[81] H. Takeshima,et al. New and notable ion‐channels in the sarcoplasmic/endoplasmic reticulum: do they support the process of intracellular Ca2+ release? , 2015, The Journal of physiology.
[82] R. Janicek,et al. Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy. , 2015, Cell calcium.
[83] M. Kuum,et al. Potassium fluxes across the endoplasmic reticulum and their role in endoplasmic reticulum calcium homeostasis. , 2015, Cell calcium.
[84] E. McNally,et al. The Dystrophin Complex: Structure, Function, and Implications for Therapy. , 2015, Comprehensive Physiology.
[85] J. Molkentin,et al. Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy , 2015, Cell Death and Differentiation.
[86] J. Molkentin,et al. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. , 2015, American journal of physiology. Cell physiology.
[87] Jeovanna Lowe,et al. Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy , 2015, PloS one.
[88] John M. Shelton,et al. A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance , 2015, Cell.
[89] Andrew D. Williams,et al. Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency , 2014, PloS one.
[90] Jose A. Adams,et al. Age-dependent changes in diastolic Ca(2+) and Na(+) concentrations in dystrophic cardiomyopathy: Role of Ca(2+) entry and IP3. , 2014, Biochemical and biophysical research communications.
[91] J. Molkentin,et al. Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy. , 2014, Human molecular genetics.
[92] L. Hool,et al. Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart , 2014, Proceedings of the National Academy of Sciences.
[93] L. Tian,et al. Gene expression profiling of Duchenne muscular dystrophy reveals characteristics along disease progression. , 2014, Genetics and molecular research : GMR.
[94] G. Obermair,et al. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. , 2014, American journal of physiology. Heart and circulatory physiology.
[95] B. Constantin. Dystrophin complex functions as a scaffold for signalling proteins. , 2014, Biochimica et biophysica acta.
[96] D. Kass,et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.
[97] D. Kass,et al. Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP–Protein Kinase G Modulation , 2014, Circulation research.
[98] C. Henríquez-Olguín,et al. Nifedipine Treatment Reduces Resting Calcium Concentration, Oxidative and Apoptotic Gene Expression, and Improves Muscle Function in Dystrophic mdx Mice , 2013, PloS one.
[99] S. Boncompagni,et al. Orai1-dependent Calcium Entry Promotes Skeletal Muscle Growth and Limits Fatigue , 2013, Nature Communications.
[100] S. Moro,et al. The mitochondrial calcium uniporter is a multimer that can include a dominant‐negative pore‐forming subunit , 2013, The EMBO journal.
[101] Jerry R Mendell,et al. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy , 2013, Muscle & nerve.
[102] D. Fraidenraich,et al. Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.
[103] Y. Mori,et al. Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+/calmodulin‐dependent kinase II , 2013, The Journal of physiology.
[104] N. Déliot,et al. Involvement of TRPV2 and SOCE in calcium influx disorder in DMD primary human myotubes with a specific contribution of α1-syntrophin and PLC/PKC in SOCE regulation. , 2013, American journal of physiology. Cell physiology.
[105] E. Niggli,et al. Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. , 2013, Cardiovascular research.
[106] Carthene R. Bazemore-Walker,et al. In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM). , 2013, Journal of proteomics.
[107] Xiaoli Zhao,et al. Orai1 Mediates Exacerbated Ca2+ Entry in Dystrophic Skeletal Muscle , 2012, PloS one.
[108] M. Falzarano,et al. The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms , 2012, PloS one.
[109] F. Sbrana,et al. Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy , 2012, Science Signaling.
[110] Kevin M Flanigan,et al. The Muscular Dystrophies , 1999, Seminars in Neurology.
[111] T. Molinski,et al. Increased Resting Intracellular Calcium Modulates NF-κB-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes* , 2012, The Journal of Biological Chemistry.
[112] M. Weber,et al. Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone , 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[113] H. Lochmüller,et al. P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment , 2012, Journal of cellular and molecular medicine.
[114] H. Hosoi,et al. The Shortest Isoform of Dystrophin (Dp40) Interacts with a Group of Presynaptic Proteins to Form a Presumptive Novel Complex in the Mouse Brain , 2012, Molecular Neurobiology.
[115] Y. Jan,et al. Activity of the mitochondrial calcium uniporter varies greatly between tissues , 2012, Nature Communications.
[116] Kumaraswamy Nanthakumar,et al. Role of KATP Channels in the Maintenance of Ventricular Fibrillation in Cardiomyopathic Human Hearts , 2011, Circulation research.
[117] L. Tessarollo,et al. Dystrophin Is Required for the Normal Function of the Cardio-Protective KATP Channel in Cardiomyocytes , 2011, PloS one.
[118] R. Hajjar,et al. SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice , 2011, Journal of Translational Medicine.
[119] I. Ambudkar,et al. Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .
[120] V. Mootha,et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.
[121] Ju Chen,et al. The costamere bridges sarcomeres to the sarcolemma in striated muscle. , 2011, Progress in pediatric cardiology.
[122] Ching-On Wong,et al. cAMP Activates TRPC6 Channels via the Phosphatidylinositol 3-Kinase (PI3K)-Protein Kinase B (PKB)-Mitogen-activated Protein Kinase Kinase (MEK)-ERK1/2 Signaling Pathway* , 2011, The Journal of Biological Chemistry.
[123] R. Hajjar,et al. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. , 2011, The Journal of clinical investigation.
[124] C. Matsumura,et al. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF‐β1 blocker , 2011, Muscle & nerve.
[125] C. Bourcier-Lucas,et al. Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. , 2011, American journal of physiology. Heart and circulatory physiology.
[126] J. Molkentin,et al. Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice , 2010, Neuromuscular Disorders.
[127] R. Gejman,et al. Abnormal distribution of inositol 1,4,5‐trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy‐derived cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[128] F. von Wegner,et al. Upregulation of store-operated Ca2+ entry in dystrophic mdx mouse muscle. , 2010, American journal of physiology. Cell physiology.
[129] J. Kornegay,et al. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.
[130] R. Finkel,et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.
[131] S. Matecki,et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.
[132] C. Cognard,et al. Regulation by scaffolding proteins of canonical transient receptor potential channels in striated muscle , 2009, Journal of Muscle Research and Cell Motility.
[133] V. Shoshan-Barmatz,et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange , 2009, Proceedings of the National Academy of Sciences.
[134] Jonathan T. Pierce-Shimomura,et al. The Dystrophin Complex Controls BK Channel Localization and Muscle Activity in Caenorhabditis elegans , 2009, PLoS genetics.
[135] B. Aronow,et al. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.
[136] R. Matsuda,et al. Ectopic calcification is caused by elevated levels of serum inorganic phosphate in mdx mice. , 2009, Cell structure and function.
[137] C. Cognard,et al. Regulation of TRPC1 and TRPC4 Cation Channels Requires an α1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes* , 2009, The Journal of Biological Chemistry.
[138] D. Clapham,et al. Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter , 2009, Science.
[139] M. Marques,et al. Sarcoplasmic–endoplasmic–reticulum Ca2+‐ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin‐deficient mdx mice , 2009, Muscle & nerve.
[140] A. R. Tupling. The decay phase of Ca2+ transients in skeletal muscle: regulation and physiology. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[141] Yuji Arai,et al. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. , 2009, Human molecular genetics.
[142] S. Matecki,et al. Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.
[143] C. Matsumura,et al. Diltiazem and verapamil protect dystrophin‐deficient muscle fibers of MDX mice from degeneration: A potential role in calcium buffering and sarcolemmal stability , 2009, Muscle & nerve.
[144] D. Gillespie,et al. Intracellular calcium release channels mediate their own countercurrent: the ryanodine receptor case study. , 2008, Biophysical journal.
[145] O. Dorchies,et al. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy , 2008, British journal of pharmacology.
[146] Elisabetta Cerbai,et al. Role of potassium currents in cardiac arrhythmias. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[147] U. Ruegg,et al. Nav1.4 Deregulation in Dystrophic Skeletal Muscle Leads to Na+ Overload and Enhanced Cell Death , 2008, The Journal of general physiology.
[148] D. Allen,et al. TRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophy , 2008, Journal of Cell Science.
[149] H. Sweeney,et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy , 2008, Nature Medicine.
[150] E. Niggli,et al. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. , 2008, Cardiovascular research.
[151] E. Olson,et al. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[152] Y. Katanosaka,et al. Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors. , 2007, The American journal of pathology.
[153] G. Billman,et al. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. , 2007, Journal of molecular and cellular cardiology.
[154] J. Gillis,et al. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin‐lacking mdx mice , 2007, The Journal of physiology.
[155] T. Ogura,et al. TRIC channels are essential for Ca2+ handling in intracellular stores , 2007, Nature.
[156] Joseph P. Yuan,et al. STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels , 2007, Nature Cell Biology.
[157] Tobias Meyer,et al. Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2+ store depletion , 2007, Proceedings of the National Academy of Sciences.
[158] M. Periasamy,et al. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. , 2007, Journal of molecular and cellular cardiology.
[159] Anuradha Kalyanasundaram,et al. SERCA pump isoforms: Their role in calcium transport and disease , 2007, Muscle & nerve.
[160] C. Cognard,et al. Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[161] P. Várnai,et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.
[162] B. Wong,et al. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers , 2006, Neuromuscular Disorders.
[163] G. Salido,et al. Interaction of STIM1 with Endogenously Expressed Human Canonical TRP1 upon Depletion of Intracellular Ca2+ Stores* , 2006, Journal of Biological Chemistry.
[164] Patrick Ruchat,et al. Cardiac Sodium Channel Nav1.5 Is Regulated by a Multiprotein Complex Composed of Syntrophins and Dystrophin , 2006, Circulation research.
[165] B. Allard. Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres , 2006, Journal of Muscle Research & Cell Motility.
[166] S. Wagner,et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function , 2005, The Journal of cell biology.
[167] A. Kurosky,et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells , 2005, Nature Cell Biology.
[168] G. Mironova,et al. Functional Distinctions between the Mitochondrial ATP-dependent K+ Channel (mitoKATP) and Its Inward Rectifier Subunit (mitoKIR)* , 2004, Journal of Biological Chemistry.
[169] Yuan-Ping Pang,et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.
[170] Susan C. Brown,et al. Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion , 2004, Neurobiology of Disease.
[171] S. Carbonetto,et al. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. , 2003, Human molecular genetics.
[172] K. Dietzmann,et al. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse , 1998, Molecular and Cellular Biochemistry.
[173] T. Gudermann,et al. N-Linked Protein Glycosylation Is a Major Determinant for Basal TRPC3 and TRPC6 Channel Activity* , 2003, Journal of Biological Chemistry.
[174] A. Colell,et al. Cholesterol Impairs the Adenine Nucleotide Translocator-mediated Mitochondrial Permeability Transition through Altered Membrane Fluidity* , 2003, Journal of Biological Chemistry.
[175] Yuji Arai,et al. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor–regulated channel , 2003, The Journal of cell biology.
[176] K. Ohlendieck,et al. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. , 2003, European journal of cell biology.
[177] C. Cognard,et al. Na+/Ca2+ exchange in human myotubes: intracellular calcium rises in response to external sodium depletion are enhanced in DMD , 2002, Neuromuscular Disorders.
[178] H. Debaix,et al. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers , 2002, The Journal of cell biology.
[179] Andrew P. Weir,et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.
[180] M. Bucan,et al. Running endurance abnormality in mdx mice , 2002, Muscle & nerve.
[181] Lawrence Salkoff,et al. SLO-1 Potassium Channels Control Quantal Content of Neurotransmitter Release at the C. elegans Neuromuscular Junction , 2001, Neuron.
[182] A. Comtois,et al. Dystrophin‐deficient cardiomyocytes are abnormally vulnerable to mechanical stress‐induced contractile failure and injury , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[183] C. Cognard,et al. Cationic channels in normal and dystrophic human myotubes , 2001, Neuromuscular Disorders.
[184] L. Salkoff,et al. SLO-2, a K+ channel with an unusual Cl− dependence , 2000, Nature Neuroscience.
[185] B. Allard,et al. Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[186] C. Schöneich,et al. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. , 1999, Biochemistry.
[187] C. Schöneich,et al. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. , 1999, The Biochemical journal.
[188] K. Föhr,et al. Increased calcium entry into dystrophin‐deficient muscle fibres of MDX and ADR‐MDX mice is reduced by ion channel blockers , 1999, The Journal of physiology.
[189] J A Powell,et al. Differences in both inositol 1,4,5‐trisphosphate mass and inositol 1,4,5‐trisphosphate receptors between normal and dystrophic skeletal muscle cell lines , 1998, Muscle & nerve.
[190] J. Caldwell,et al. Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins , 1998, The Journal of Neuroscience.
[191] C. Schöneich,et al. Identification of oxidation-sensitive peptides within the cytoplasmic domain of the sarcoplasmic reticulum Ca2+-ATPase. , 1997, Biochemistry.
[192] B. Allard,et al. Similarity of ATP‐dependent K+ channels in skeletal muscle fibres from normal and mutant mdx mice. , 1997, The Journal of physiology.
[193] A. Hühmer,et al. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca‐ATPase of rat skeletal muscle during aging: a peroxynitrite‐mediated process? , 1996, FEBS letters.
[194] R. Levi,et al. Properties of cardiac cells from dystrophic mouse. , 1995, Journal of molecular and cellular cardiology.
[195] E. Hoffman,et al. Phospholipase A2 activity in dystrophinopathies , 1995, Neuromuscular Disorders.
[196] R. Gilmour,et al. Reduction of the transient outward potassium current in canine x‐linked muscular dystrophy , 1994, Circulation.
[197] H. Sweeney,et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[198] A. Torroni,et al. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. , 1992, The Journal of biological chemistry.
[199] A. Emery. Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.
[200] A. Monaco,et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.
[201] A. Emery,et al. Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. , 1980, British medical journal.